IRIS
DE MARCHI, Fabiola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.025
NA - Nord America 993
AS - Asia 783
SA - Sud America 7
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.812
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 963
IE - Irlanda 618
IT - Italia 406
SG - Singapore 364
HK - Hong Kong 277
DE - Germania 245
SE - Svezia 222
RU - Federazione Russa 199
UA - Ucraina 83
CN - Cina 49
FI - Finlandia 39
FR - Francia 38
GB - Regno Unito 29
CA - Canada 28
NL - Olanda 25
EE - Estonia 21
IR - Iran 21
CZ - Repubblica Ceca 19
IN - India 18
AT - Austria 16
TR - Turchia 15
ID - Indonesia 13
PL - Polonia 12
DK - Danimarca 11
VN - Vietnam 11
BE - Belgio 10
RO - Romania 10
BR - Brasile 7
JP - Giappone 6
LT - Lituania 6
CH - Svizzera 4
ES - Italia 4
GR - Grecia 2
JO - Giordania 2
PA - Panama 2
PH - Filippine 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
EG - Egitto 1
EU - Europa 1
IM - Isola di Man 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
NG - Nigeria 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 3.812
Salva come PNG Salva come JPEG
Città #
Dublin 614
Hong Kong 275
Singapore 145
Jacksonville 140
Moscow 69
Chandler 67
Dearborn 58
Novara 51
Mülheim 44
Lawrence 35
Princeton 35
Turin 35
Boardman 34
Wilmington 32
Milan 30
Helsinki 27
Munich 25
Bremen 24
Strasbourg 24
Beijing 23
Rome 17
San Mateo 17
Dallas 16
Toronto 16
Brno 15
Frankfurt am Main 15
Piemonte 14
Falkenstein 13
Vercelli 13
Amsterdam 12
Nuremberg 12
Zanjan 12
Ashburn 11
Jakarta 11
Seattle 11
Vienna 11
Brussels 10
Monmouth Junction 10
Kocmyrzów 9
Kocaeli 8
Borgomanero 7
Houston 7
Ottawa 7
Ann Arbor 6
Cassano Magnago 6
London 6
Santa Clara 6
Ardabil 5
Brescia 5
Espoo 5
Los Angeles 5
Radauti 5
Sannomaru 5
Assago 4
Cologne 4
Dong Ket 4
Hefei 4
Menlo Park 4
Nanjing 4
São Paulo 4
Trieste 4
Venice 4
Winchester 4
Zurich 4
Cambridge 3
Fairfield 3
Foglizzo 3
Gainesville 3
Genoa 3
Guarulhos 3
Leawood 3
Pavia 3
Reggio Emilia 3
Rimini 3
San Antonio 3
San Benedetto del Tronto 3
Stanmore 3
Woodbridge 3
Alanís 2
Almere Stad 2
Amman 2
Andover 2
Angers 2
Ankara 2
Athens 2
Augusta 2
Barcelona 2
Belgrade 2
Cattolica 2
Davoli 2
Erding 2
Flushing 2
Fusignano 2
Guangzhou 2
Hanoi 2
Honolulu 2
Istanbul 2
Jinan 2
Lissone 2
Manila 2
Totale 2.245
Salva come PNG Salva come JPEG
Nome #
Acetyl-L-carnitine and Amyotrophic Lateral Sclerosis: current evidence and potential use. 159
Analysis of the GCG Repeat Length in NIPA1 Gene in C9orf72-mediated ALS in a Large Italian ALS Cohort 95
Advances in stem cell therapy for amyotrophic lateral sclerosis 94
ALS Phenotype Is Influenced by Age, Sex, and Genetics: A Population-Based Study 94
A case of late-onset OCD developing PLS and FTD 80
A case of marchiafava bignami disease with frontal cortex involvement and late onset, long-lasting psychiatric symptoms 75
A case of Progressive Non-Fluent Aphasia as onset of Amyotrophic Lateral Sclerosis with FrontoTemporal Dementia 73
Characterization of the c9orf72 GC-rich low complexity sequence in two cohorts of Italian and Turkish ALS cases 72
The length of SNCA Rep1 microsatellite may influence cognitive evolution in Parkinson’s disease 68
Expanding the genetic spectrum of primary familial brain calcification due to SLC2OA2 mutations: a case series 68
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 66
Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trial 64
Ptosis and bulbar onset: an unusual phenotype of familial ALS? 64
Chronic obstructive pulmonary disease may complicate Alzheimer's disease: a comorbidity problem 64
Potential Role of Gut Microbiota in ALS Pathogenesis and Possible Novel Therapeutic Strategies 63
Headache in immigrant patients: similarities and differences with Italian population 62
Intraspinal stem cell transplantation for amyotrophic lateral sclerosis: Ready for efficacy clinical trials? 62
Frontotemporal Dementia Presenting as Gambling Disorder: When a Psychiatric Condition Is the Clue to a Neurodegenerative Disease 58
Study protocol on the safety and feasibility of a normocaloric ketogenic diet in people with amyotrophic lateral sclerosis 58
Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study 56
Detection of white matter ultrastructural changes for amyotrophic lateral sclerosis characterization: A diagnostic study from DTI-derived data 55
Functional status and oral health in patients with amyotrophic lateral sclerosis: A cross-sectional study 54
A prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis 54
Marchiafava-Bignami Disease with frontal cortex involvement and late onset, long-lasting psychiatric symptoms: A case report 53
Depression and risk of Cognitive Dysfunctions in Amyotrophic Lateral Sclerosis 53
The Potential Role of Peripheral Oxidative Stress on the Neurovascular Unit in Amyotrophic Lateral Sclerosis Pathogenesis: A Preliminary Report from Human and In Vitro Evaluations 53
Occipital Neuralgia in Chiari I Malformation: Two Different Events or Two Different Faces of the Same Event? 51
The prevention of falls in patients with Parkinson's disease with in-home monitoring using a wearable system: a pilot study protocol 50
Telemedicine and technological devices for amyotrophic lateral sclerosis in the era of COVID-19 50
Predicting Cognitive Decline in Parkinson's Disease: Can We Ask the Genes? 49
Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: A population-based study 49
Polymorphisms of dopamine receptor genes and risk of visual hallucinations in Parkinson's patients 48
Results from Phase I Clinical Trial with Intraspinal Injection of Neural Stem Cells in Amyotrophic Lateral Sclerosis: A Long-Term Outcome 45
Neurological emergency at the COVID-19 pandemic: report from a referral hospital in Eastern Piedmont, Italy 45
C9ORF72 Repeat Expansion Affects the Proteome of Primary Skin Fibroblasts in ALS 44
Telehealth Approach For Amyotrophic Lateral Sclerosis Patients: The experience during COVID-19 pandemic 44
Telehealth in neurodegenerative diseases: Opportunities and challenges for patients and physicians 44
The Role of Tau beyond Alzheimer’s Disease: A Narrative Review 42
A pilot trial of RNS60 in amyotrophic lateral sclerosis 41
Rapamycin treatment for amyotrophic lateral sclerosis: Protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial) 36
Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants 36
Adopting Assistive Technologies in Healthcare Processes: A Chatbot for Patients with Amyotrophic Lateral Sclerosis 36
Decline of cognitive and behavioral functions in amyotrophic lateral sclerosis: a longitudinal study 35
Critical illness neuro-myopathy (CINM) and focal amyotrophy in intensive care unit (ICU) patients with SARS-CoV-2: a case series 35
Exploring the phenotype of Italian patients with ALS with intermediate ATXN2 polyQ repeats 35
Accelerated early progression of amyotrophic lateral sclerosis over the covid-19 pandemic 35
What is amyotrophic lateral sclerosis prevalence? 34
Characterization of the p.L145F and p.S135N Mutations in SOD1: Impact on the Metabolism of Fibroblasts Derived from Amyotrophic Lateral Sclerosis Patients 32
Clinical relevance of single-subject brain metabolism patterns in amyotrophic lateral sclerosis mutation carriers 32
Editorial: What's next? Innovative translational markers across the ALS-FTD continuum 31
A Telehealth Intervention for Nutritional Counseling in Amyotrophic Lateral Sclerosis Patients 30
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology 30
Gastrointestinal Status and Microbiota Shaping in Amyotrophic Lateral Sclerosis: A New Frontier for Targeting? 30
Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses 29
The Need for Biomarkers in the ALS-FTD Spectrum: A Clinical Point of View on the Role of Proteomics 29
Pharmacotherapy for Amyotrophic Lateral Sclerosis: A Review of Approved and Upcoming Agents 29
Clinical and Metabolic Signature of UNC13A rs12608932 Variant in Amyotrophic Lateral Sclerosis 28
Respiratory support in a population-based ALS cohort: Demographic, timing and survival determinants 27
Plateaus in amyotrophic lateral sclerosis progression: results from a population-based cohort 27
A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine 27
Adjusted cost analysis of video televisits for the care of people with amyotrophic lateral sclerosis 26
Factors associated with the severity of COVID-19 outcomes in people with neuromuscular diseases: Data from the International Neuromuscular COVID-19 Registry 26
New Insights into the Relationship between Nutrition and Neuroinflammation in Alzheimer's Disease: Preventive and Therapeutic Perspectives 26
Validation of the DYALS (dysphagia in amyotrophic lateral sclerosis) questionnaire for the evaluation of dysphagia in ALS patients 25
Cognitive dysfunction in amyotrophic lateral sclerosis: can we predict it? 25
Interplay between immunity and amyotrophic lateral sclerosis: Clinical impact 24
From Biomarkers to Precision Medicine in Neurodegenerative Diseases: Where Are We? 24
Clinical trials in pediatric ALS: a TRICALS feasibility study 24
Generation of an induced pluripotent stem cell line, CSSi011-A (6534), from an Amyotrophic lateral sclerosis patient with heterozygous L145F mutation in SOD1 gene 24
Early weight loss in amyotrophic lateral sclerosis: outcome relevance and clinical correlates in a population-based cohort 24
Association of Copresence of Pathogenic Variants Related to Amyotrophic Lateral Sclerosis and Prognosis 23
Shotgun Proteomics Links Proteoglycan-4+ Extracellular Vesicles to Cognitive Protection in Amyotrophic Lateral Sclerosis 23
Amyotrophic lateral sclerosis regional progression intervals change according to time of involvement of different body regions 23
Patient reported outcome measures (PROMs) in amyotrophic lateral sclerosis 23
Patient reported outcomes in ALS: characteristics of the self-entry ALS Functional Rating Scale-revised and the Activities-specific Balance Confidence Scale 21
Exposure to electromagnetic fields does not modify neither the age of onset nor the disease progression in ALS patients 21
Do ecological factors influence the clinical presentation of amyotrophic lateral sclerosis? 21
Effects of Acetyl-L-Carnitine on Oxidative Stress in Amyotrophic Lateral Sclerosis Patients: Evaluation on Plasma Markers and Members of the Neurovascular Unit 20
Reply to: Amyotrophic lateral sclerosis with depression, cognitive impairment, and mortality 20
Investigating the Prognostic Role of Peripheral Inflammatory Markers in Mild Cognitive Impairment 20
Cell therapy in ALS: An update on preclinical and clinical studies 19
Exploring the use of educational materials for increasing participation in a stretching program: a quality improvement project in people with motor neuron disease 19
Factors predicting disease progression in C9ORF72 ALS patients 19
Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis 19
Potential role of vitamin D levels in amyotrophic lateral sclerosis cognitive impairment 19
Tailoring patients' enrollment in ALS clinical trials: the effect of disease duration and vital capacity cutoffs 19
iPSC-based research in ALS precision medicine 19
Emerging Trends in the Field of Inflammation and Proteinopathy in ALS/FTD Spectrum Disorder 18
The diagnostic and prognostic role of biomarkers for amyotrophic lateral sclerosis 18
From Mild Cognitive Impairment to Dementia: The Impact of Comorbid Conditions on Disease Conversion 17
Novel Therapeutic Strategies in Alzheimer's Disease: Pitfalls and Challenges of Anti-Amyloid Therapies and Beyond 17
The NEALS primary lateral sclerosis registry 17
Overlapping Neuroimmune Mechanisms and Therapeutic Targets in Neurodegenerative Disorders 17
Withdrawal of mechanical ventilation in amyotrophic lateral sclerosis patients: a multicenter Italian survey 16
Circulating GLAST+ EVs are increased in amyotrophic lateral sclerosis 16
Integration of a palliative care specialist in an amyotrophic lateral sclerosis clinic: Observations from one center 15
Effect of mesenchymal stromal cell transplantation on long-term survival in amyotrophic lateral sclerosis 15
null 15
Current status and new avenues of stem cell-based preclinical and therapeutic approaches in amyotrophic lateral sclerosis 13
Sex Differences in Amyotrophic Lateral Sclerosis Survival and Progression: A Multidimensional Analysis 13
Totale 3.885
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.083
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.083
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202062 0 0 0 0 0 0 0 0 0 34 28 0
2020/2021245 24 2 22 2 41 14 48 9 32 9 34 8
2021/2022304 20 11 15 26 16 7 2 7 23 16 73 88
2022/20231.230 45 56 40 10 82 88 46 54 667 17 98 27
2023/2024571 50 38 80 29 82 20 76 5 13 5 50 123
2024/20251.271 45 38 125 36 50 196 120 164 339 158 0 0
Totale 3.992